BNT162b2 Vaccine Booster and Mortality Due to Covid-19

BACKGROUND: The emergence of the B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 and the reduced effectiveness over time of the BNT162b2 vaccine (Pfizer–BioNTech) led to a resurgence of coronavirus disease 2019 (Covid-19) cases in populations that had been vaccinated ear...

Descripción completa

Detalles Bibliográficos
Autores principales: Arbel, Ronen, Hammerman, Ariel, Sergienko, Ruslan, Friger, Michael, Peretz, Alon, Netzer, Doron, Yaron, Shlomit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728797/
https://www.ncbi.nlm.nih.gov/pubmed/34879190
http://dx.doi.org/10.1056/NEJMoa2115624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728797/
https://www.ncbi.nlm.nih.gov/pubmed/34879190
http://dx.doi.org/10.1056/NEJMoa2115624

Ejemplares similares